About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01792427

Mortality in Non-cystic Fibrosis Bronchiectasis

In this study we analyzed the overall survival for all newly diagnosed patients with non-cystic fibrosis bronchiectasis from June 2006 onwards. The investigators wanted to confirm the known risk facto...

Lead sponsor: Universitaire Ziekenhuizen KU Leuven•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Universitaire Ziekenhuizen KU Leuven

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with clinically significant and radiologically proven bronchiectasis
•Chest CT scan confirming the presence of bronchiectatic lesions and had symptoms of chronic productive cough
•Bronchiectasis was deemed to be present if there was one or more of the following criteria: a bronchoarterial ratio greater than 1, lack of tapering of the bronchi and visualization of bronchi within 1 cm of costal or paravertebral pleura or abutting the mediastinal pleura

Exclusion Criteria

•diagnosis of cystic fibrosis
•underlying tumoral problem causing the bronchiectatic lesions (postradiotherapy, secondary immunodeficiency due to chemotherapy or postinfectious due to tumoral obstruction)
•patients with asymptomatic traction bronchiectasis caused by interstitial lung disease

Related studies

RECRUITINGPhase 1

A Clinical Study of RSS0343 in Healthy Subjects

NCT07289464 · Non-cystic Fibrosis Bronchiectasis

Not Yet RecruitingPhase 4

Azithromycin to Modify Bronchiectasis Exacerbation Risk

NCT07608328 · Non-cystic Fibrosis Bronchiectasis, Bronchiectasis Adult, and more

COMPLETEDPhase 3

A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

NCT04594369 · Non-Cystic Fibrosis Bronchiectasis

Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH

NCT06237348 · Non-cystic Fibrosis Bronchiectasis, Chronic Mucus Hypersecretion

TERMINATEDPhase 1

A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

NCT04656275 · Non-cystic Fibrosis Bronchiectasis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 20, 2013Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment253

Start dateJun 2006

Last updatedFeb 20, 2013

Condition

Non-cystic Fibrosis Bronchiectasis

Locations shown

UZ Leuven

Leuven, Vlaams-Brabant

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions